Skip to main content
. 2023 May 19;29:1611162. doi: 10.3389/pore.2023.1611162

FIGURE 1.

FIGURE 1

Immunohistochemistry-based classification scheme according to Zhao et al. [10]. Abbreviations: BLIS, basal-like immunosuppressed; IM, immunomodulatory; LAR, luminal androgen receptor; MES, mesenchymal-like; TNBC, triple-negative breast cancer; UC, unclassifiable.